Skip to content

Drugs for Neglected Diseases initiative (DNDi)

Categories: Climate Resilient Health Systems, Low Carbon Sustainable Health Systems, GHG emissions baseline assessments, Action Plans for sustainable low carbon health systems, Europe

Drugs for Neglected Diseases initiative (DNDi)

The Drugs for Neglected Diseases initiative (DNDi) is a not-for-profit research and development organization that discovers, develops, and delivers safe, effective, and affordable treatments for neglected patients. DNDi has developed a four-pronged strategy on health, climate, and the environment to address the treatment needs of the world’s most vulnerable populations- i) Develop treatments for climate-sensitive diseases ii) advocate for innovation and investment for neglected patients in the global climate change response iii) reduce the environmental footprint of our operations; and iv) work with partners to reduce the environmental impact of developing and manufacturing medicines.

Supporting the following commitments

  • Commitment 5: Deliver a baseline assessment of greenhouse gas emissions of the health system (including supply chains).
  • Commitment 6: Develop an action plan or roadmap by a set date to develop a sustainable low carbon health system (including supply chains).

Country experience:

N/A

Links:

Site in English: https://dndi.org/